Viral Clearance Market Size

Viral Clearance Market size was over USD 793.57 million in 2024 and is set to cross USD 8.06 billion by the end of 2037, growing at more than 19.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of viral clearance is estimated at USD 916.73 million. The growth of the market can primarily be attributed to the rising demand for specialty drugs across the globe. For instance, in 2020, the specialty drug expenditure was estimated to hit 8% while in 2019, approximately 3.5% of the global population was projected to take at least 1 specialty drug.

Global market trends such as, rising government initiatives in each country in favor of viral clearance along with spiking penetration of infectious lung diseases and noteworthy growth in healthcare expenditure are projected to influence the growth of the market positively over the forecast period. As per the statistics provided by the World Bank, it was noticed that healthcare expenditure dropped to USD 1,121.9 per capita in 2019. Viral clearance is the difference found between the quantity of virus in the input sample and the fraction containing the product after purification. Moreover, ongoing development in novel technology and rising awareness of viral safety is further expected to flourish the growth of the market over the forecast period.